CommercialJuly 1, 2019
Anthem Federal Employee Health Benefit Program® (FEP) PPO members will now require prior approval for specific specialty drugs and site of care
List of medications by name and code
Code |
Procedure Description |
CODE |
Procedure Description |
J0129 |
Abatacept injection (Orencia) |
J1575 |
Injection, immune globulin/hyaluronidase (HyQvia) |
J0490 |
Belimumab injection (Benlysta) |
J1599 |
Injection, immune globulin (Panzyga) |
J1459 |
Injection, immune globulin (Privigen) |
J1602 |
Golimumab IV (Simponi Aria) |
J1555 |
Injection, immune globulin (Cuvitru) |
J1745 |
Infliximab not biosimilar (Remicade) |
J1556 |
Injection, immune globulin (Bivigam) |
J2323 |
Natalizumab injection (Tysabri) |
J1557 |
Injection, immune globulin (Gammaplex) |
J3380 |
Vedolizumab Injection (Entyvio) |
J1559 |
Injection, immune globulin (Hizentra) |
Q5103 |
Infliximab dyyb biosimilar (Inflectra) |
J1561 |
Injection, immune globulin (Gamunex-c/Gammaked) |
Q5104 |
Infliximab abda biosimilar (Renflexis) |
J1566 |
Injection, immune globulin (Carimune) |
Q5109 |
infliximab-qbtx, biosimilar (Ixifi) |
J1568 |
Injection, immune globulin (Octagam) |
J1569 |
Injection, immune globulin, (Gammagard liquid) |
J1572 |
Injection, immune globulin , (Flebogamma) |
|
|
In addition to acquiring prior authorization for the medication, the outpatient hospital site of care must also be approved. The prior authorization process will identify members who meet the appropriate Anthem site of care criteria and who can safely receive their medication in a location other than an outpatient hospital, including the home.
Effective January 1, 2020 failure to receive prior authorization for these medications may result in non-coverage of the medication and facility services.
To acquire prior authorization please contact the Anthem Federal Employee Program Utilization Management Department at 800-860-2156.
PUBLICATIONS: July 2019 Anthem Provider News - Georgia
To view this article online:
Or scan this QR code with your phone